New Research Reveals the Hidden Path from Fatty Liver Disease to Cancer
Your liver is remarkably resilient. It can regenerate after injury, process toxins, manufacture essential proteins, and manage the nutrients from every meal you eat. But a groundbreaking new study published in Cell reveals that this remarkable organ has a troubling vulnerability: when faced with chronic stress from an unhealthy diet, liver cells undergo changes that can quietly set the stage for cancer years before any tumor appears.
The research, conducted by scientists at MIT, Harvard, and the University of Pittsburgh, offers a new understanding of how metabolic dysfunction-associated steatohepatitis, commonly known as MASH (formerly called NASH), progresses to liver cancer. Their findings suggest that the very strategies liver cells use to survive dietary stress may ultimately betray them.
A Growing Public Health Crisis
Fatty liver disease has become extraordinarily common, now affecting more than one-third of the global population. For most people, the condition remains relatively benign. But in a significant subset of patients, simple fatty liver progresses to MASH, characterized by inflammation and scarring. From there, some patients develop cirrhosis and ultimately liver cancer, which ranks as the second leading cause of cancer-related years of life lost worldwide.
What has puzzled scientists is why some patients progress to cancer while others do not. Previous research found that the genetic mutations typically associated with cancer do not accumulate significantly until the very late stages of liver disease. So what happens in the intervening years to make the liver vulnerable?
The Liver’s Troubling Memory
To answer this question, the research team spent 15 months tracking mice fed a high-fat diet and examining their liver cells at multiple time points, using sophisticated techniques that enabled them to measure individual-cell activity. What they discovered was striking: long before any tumors formed, liver cells were undergoing a fundamental shift in their identity.
Under chronic dietary stress, hepatocytes (the primary working cells of the liver) began activating genetic programs normally seen only during fetal development or tissue regeneration. At the same time, they were dialing down the genes responsible for the liver’s essential functions: producing blood clotting factors, manufacturing albumin, detoxifying harmful compounds, and regulating cholesterol.
The researchers describe this as a trade-off. Faced with ongoing nutritional stress, individual liver cells prioritize their own survival over their contributions to the body’s needs. They adopt a more primitive, resilient state that helps them weather the storm. The problem is that this survival mode also resembles the early stages of cancer.
How Stress Gets Under the Cell’s Skin
Perhaps most alarming was the discovery that these changes are not just temporary responses. The researchers found evidence of epigenetic priming, meaning that the cells were physically reorganizing their DNA in ways that make cancer-associated genes easier to activate in the future.
Think of DNA as a massive instruction manual, with most pages locked shut. Epigenetic changes are like placing bookmarks that make certain pages easier to flip to. The research showed that dietary stress causes cells to bookmark pages related to cell proliferation and the WNT signaling pathway, both of which are hyperactive in many liver cancers.
These epigenetic changes emerged early in the disease process and persisted over time, forming a molecular memory of past stress. When the researchers examined the cells’ DNA accessibility patterns, they found changes at six months that foreshadowed which genes would become problematic at 15 months.
A Key Metabolic Switch
The team identified a crucial enzyme called HMGCS2 that appears central to this process. This enzyme is essential for ketogenesis, the metabolic pathway that converts fats into ketone bodies. In healthy livers, HMGCS2 is highly active. But under chronic dietary stress, its levels drop progressively.
To test whether this decline actually mattered, the researchers created mice lacking HMGCS2 specifically in their livers. When these mice were fed a high-fat diet and then given genetic triggers for cancer, they developed significantly more tumors than normal mice on the same diet. The loss of this single enzyme was enough to accelerate the cellular changes associated with dietary stress and increase cancer susceptibility.
Importantly, lower HMGCS2 expression in human patients also predicted worse outcomes. People with reduced HMGCS2 levels in their non-cancerous liver tissue were more likely to develop liver cancer up to 15 years later.
Finding the Master Switches
The researchers also developed new computational methods to identify transcription factors, the proteins that act as master switches controlling which genes are turned on or off. Two factors emerged as particularly important: SOX4 and RELB.
SOX4 is normally active during fetal development when the liver is first forming. RELB is part of a signaling system involved in inflammation and immune responses. When the researchers artificially increased these factors in liver cells, the cells behaved as if under chronic stress, activating survival programs and impairing their normal functions.
In living mice, forcing liver cells to produce extra SOX4 accelerated the stress response and increased cell proliferation. The cells looked and acted as if they had experienced months of dietary stress, all from manipulating a single molecular switch.
The Neighborhood Effect
Using cutting-edge spatial transcriptomics technology, the researchers mapped the precise locations of different cell types within human liver tissue from MASH patients. They discovered that stressed liver cells tend to cluster in specific neighborhoods alongside certain immune cells and blood vessel cells.
Particularly notable were scar-associated macrophages, immune cells previously linked to liver fibrosis. These cells were consistently found near the most stressed hepatocytes, suggesting a damaging feedback loop where signals from neighboring cells might perpetuate or worsen the stress response.
What This Means for Patients
The findings have significant implications for how we think about liver disease and cancer prevention. First, they suggest that the seeds of liver cancer may be planted years or even decades before any tumor is detectable. The cellular changes identified in this study could potentially serve as early warning signs, allowing doctors to identify patients at the highest risk long before cancer develops.
Second, the research raises hope for new therapeutic approaches. Drugs that target the master regulators identified in this study, or that restore normal HMGCS2 function, might be able to reset liver cells to a healthier state. Intriguingly, some existing drugs may already have relevant effects. The first FDA-approved treatment for MASH with fibrosis, resmetirom (approved in 2024), targets a receptor that the researchers identified as potentially beneficial.
Third, the study underscores the importance of early intervention for fatty liver disease. The epigenetic changes observed in this research suggest that the liver may retain a memory of past dietary insults. This raises important questions about whether and to what extent lifestyle changes or medical treatments can erase that memory, even after patients improve their diet and exercise habits.
A Window into Cellular Stress
The researchers note that similar patterns of stress-induced cellular changes have been observed in other organs. Inflammatory episodes in the skin and pancreas have been shown to create lasting epigenetic memories that affect how tissues respond to future challenges. The liver findings fit into a broader understanding of how environmental stresses get encoded into our cells’ instruction manuals.
Remarkably, the stress response programs identified in this study were not specific to diet-related liver disease. They also appeared in patients with liver damage from alcohol or viral hepatitis, suggesting that diverse insults may converge on common cellular pathways. This could explain why different types of chronic liver disease all carry elevated cancer risk.
Looking Forward
This research represents a significant advance in our understanding of how chronic disease leads to cancer. Rather than focusing solely on genetic mutations, it reveals how cells’ adaptive responses to stress can inadvertently create the conditions for future malignancy. The liver’s remarkable ability to survive and regenerate may, under the wrong circumstances, become the source of its vulnerability.
For the millions of people living with fatty liver disease, the message is one of urgency but also hope. Urgency because the cellular changes that precede cancer begin early and accumulate over time. Hope because understanding these mechanisms opens new avenues for prevention and treatment. By learning to read the liver’s stress signals, scientists may be able to intervene before those signals become a cancer diagnosis.
